N/A
Completed N=42
Mobile After-Care Support App: Pilot RCT
Source: ClinicalTrials.gov NCT03955250 ↗Enrolled (actual)
42
Serious AEs
47.6%
Results posted
Aug 2023
Primary outcomePrimary: Client Satisfaction Questionnaire (CSQ) — 23.7; 22.5 score on a scale — p=>0.05
Summary
The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of the app. To achieve the specific aims, the investigators will conduct a pilot randomized clinical trial (n = 60), with two treatment arms: MACS vs. a mobile app attention control condition.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Client Satisfaction Questionnaire (CSQ) |
23.7; 22.5 | >0.05 |
| SECONDARY Brief Psychiatric Rating Scale (BPRS) |
53.1; 49.8; 36.4; 33.1 | <0.05 sig |
| SECONDARY Brief Adherence Rating Scale (BARS) |
86.2; 83.8; 94.4; 92.0 | >0.05 |
| SECONDARY Brief Cope Inventory (Brief COPE) |
28.6; 28.1; 24.8; 24.4 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- recently hospitalized
- DSM-5 criteria for psychotic-spectrum disorder based on structured clinical interview
- 18 years or older
- prescribed antipsychotic medication upon discharge
- ability to speak and read English
Exclusion Criteria
- substance use disorders at severe level
- planned discharge to supervised living setting or participation in formal outpatient adherence programs
- pregnancy or other medical condition contraindicating use of antipsychotic medications
Data sourced from ClinicalTrials.gov (NCT03955250). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.